staceywhite, Author at European Medical Journal - Page 132 of 194

This site is intended for healthcare professionals

Continue
2 Mins
10 Aug 2017

Longitudinal Assessment of Cognitive Functions and Quality of Life in Long Surviving Patients with Glioblastoma

Long surviving glioblastomas (GBM) are defined as when cases have an overall survival of >5 years from the diagnosis of GBM, accounting for 5% of all…
10 Mins
10 Aug 2017

Central Nervous System Disease Associated with Major Viral Haemorrhagic Fever Viruses of Public Health Importance: Challenges in Patient Diagnosis, Evaluation, and Management in Resource-Limited Settings

Viral haemorrhagic fever (VHF) viruses cause infectious diseases that are of public health importance. Billions of people from all over the world are at…
1 Mins
10 Aug 2017

Glioneuronal Tumours

Glioneuronal tumours are histologically mixed neuronal and glial tumours, according to the World Health Organization (WHO) Classification of 2016.
6 Mins
10 Aug 2017

Neurosyphilis: An Important Cause of Recurrent Strokes

Neurosyphilis can manifest as recurrent brain infarction, although not frequently, but can be challenging to diagnose due to atypical presentations.
5 Mins
10 Aug 2017

Focus on the Endogenous Cannabinoid System in Migraine

Migraine prophylaxis represents a better choice than symptomatic drugs, both for safety and for effectiveness.
9 Mins
8 Aug 2017

Improving Treatment Strategies for Patients with Follicular Lymphoma: How to Translate Novel Study Data into Clinical Practice

Ms Rosmarie Pfau detailed the challenges faced by patients with FL around the world, particularly a desire for improved quality of life (QoL) and…
2 Mins
8 Aug 2017

The Simm Study: Survey of Integrative Medicine in Myeloproliferative Neoplasms

In patients with myeloproliferative neoplasms (MPN), including essential thrombocytosis (ET), polycythaemia vera (PV), and myelofibrosis (MF), symptoms…
2 Mins
8 Aug 2017

Targeting Nanoparticles to Chronic Lymphocytic Leukaemia: Exploiting the Properties of CXCR4

A key aim of modern cancer medicine is the improvement of treatment efficacy and overall patient health using targeted therapies.
9 Mins
8 Aug 2017

Shifting Treatment Paradigms in Non-Hodgkin Lymphomas

Despite significant therapeutic advances in the treatment of patients with non-Hodgkin lymphoma (NHL), a significant proportion experience relapse or…
2 Mins
8 Aug 2017

Haemoglobin Level and White Cell Count in Patients Clinically Suspected to have Essential Thrombocythaemia may help in Predicting Early Primary Myelofibrosis or Unclassifiable Myeloproliferative Neoplasm

Accurate diagnosis of essential thrombocythaemia (ET) and differentiation between ET and pre-fibrotic stages of primary myelofibrosis (PMF) can be…
We’ve noticed you’re accessing
from North/South America.